These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12168082)

  • 1. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer.
    Hidaka S; Yasutake T; Kondo M; Takeshita H; Yano H; Haseba M; Tsuji T; Sawai T; Nakagoe T; Tagawa Y
    Anticancer Res; 2003; 23(4):3353-7. PubMed ID: 12926075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
    Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
    Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-pathologic evaluation of retroperitoneal lymph node metastasis in ovarian carcinoma].
    Takahashi Y; Chiba T; Inaba S; Yamamoto A; Nomura T; Yamamoto Y; Kasahara K; Tenzaki T; Ishiguro T; Yoshida Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1489-94. PubMed ID: 2273303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AEG -1 overexpression: a novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers.
    Li C; Liu J; Lu R; Yu G; Wang X; Zhao Y; Song H; Lin P; Sun X; Yu X; Zhang Y; Ning X; Geng J
    Int J Gynecol Cancer; 2011 May; 21(4):602-8. PubMed ID: 21543927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
    Ghadimi BM; Grade M; Liersch T; Langer C; Siemer A; Füzesi L; Becker H
    Clin Cancer Res; 2003 May; 9(5):1808-14. PubMed ID: 12738738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
    Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
    Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
    Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O
    Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer-tissue microarray analysis.
    Dimova I; Yosifova A; Zaharieva B; Raitcheva S; Doganov N; Toncheva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):81-5. PubMed ID: 15596278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology.
    Morohara K; Nakao K; Tajima Y; Nishino N; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Kawamura M; Aida T; Tachikawa T; Kusano M
    Cancer Genet Cytogenet; 2005 Aug; 161(1):57-62. PubMed ID: 16080958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
    Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of peritoneal fluid in ovarian cancer patients.
    Parrella P; Zangen R; Sidransky D; Nicol T
    Mod Pathol; 2003 Jul; 16(7):636-40. PubMed ID: 12861058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analyses of primary and metastatic serous epithelial ovarian cancer.
    Israeli O; Gotlieb WH; Friedman E; Korach J; Friedman E; Goldman B; Zeltzer A; Ben-Baruch G; Rienstein S; Aviram-Goldring A
    Cancer Genet Cytogenet; 2004 Oct; 154(1):16-21. PubMed ID: 15381367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.
    Bruchim I; Israeli O; Mahmud SM; Aviram-Goldring A; Rienstein S; Friedman E; Ben-Baruch G; Gotlieb WH
    Cancer Genet Cytogenet; 2009 Apr; 190(2):66-70. PubMed ID: 19380021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of early- versus late-stage ovarian tumors.
    Shridhar V; Lee J; Pandita A; Iturria S; Avula R; Staub J; Morrissey M; Calhoun E; Sen A; Kalli K; Keeney G; Roche P; Cliby W; Lu K; Schmandt R; Mills GB; Bast RC; James CD; Couch FJ; Hartmann LC; Lillie J; Smith DI
    Cancer Res; 2001 Aug; 61(15):5895-904. PubMed ID: 11479231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.